Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(e) 2020 Performance Bonus Plan
OnJanuary 10, 2020 , the Compensation Committee approved our 2020 Performance bonus program for our named executive officers. The 2020 annual performance bonuses for each named executive officer (as set forth in our proxy statement for our Annual Meeting of Stockholders held onMay 30, 2019 ), other than Dr.Susan Molineaux , will be based upon the achievement of corporate performance goals (80%) and individual performance goals (20%). Dr.Susan Molineaux's annual performance bonus will be based solely upon the achievement of corporate performance goals. The corporate performance goals relate to the advancement of our clinical trials, business and corporate development objectives, collaboration objectives and financial management objectives. The individual performance goals will consist of a subjective assessment of each named executive officer's individual contributions to Calithera. The following table sets forth the base salary and target bonuses for 2020: Total 2020 Target Performance Bonus as a Total 2020 Target Percentage of Performance Bonus Name 2020 Base Salary Base Salary AmountSusan Molineaux , Ph.D. President and Chief Executive Officer $ 569,250 60 % $ 341,550Keith Orford , M.D., Ph.D. Chief Medical Officer $ 455,400 40 % $ 182,160 Curtis Hecht Chief Business Officer $ 400,100 40 % $ 160,040
--------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Calithera Biosciences, Inc. Dated:January 16, 2020 By: /s/Susan M. Molineaux , Ph.D.Susan M. Molineaux , Ph.D. President and Chief Executive Officer
© Edgar Online, source